Ibrahim Ginawi
Impact in
-
- Nigella sativa pharmacological applications
Papers in
-
- Chronic Kidney Disease and Diabetes 4
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Awdah Al-Hazimi (12 shared papers)Hussain Gadelkarim Ahmed (17 shared papers)Mohammed Kuddus (1 shared paper)Ibraheem Ashankyty (4 shared papers)Abdelbaset Mohamed Elasbali (5 shared papers)Bright I. Nwaru (1 shared paper)Paola Pisani (1 shared paper)M Hakama (1 shared paper)
- Journals
- Diagnostic Cytopathology (1 paper)Journal of Obesity (1 paper)Toxicology Reports (1 paper)European Journal of Inflammation (1 paper)Acta Diabetologica (1 paper)
- Partner nations
- Saudi ArabiaSudanUnited Kingdom
In The Last Decade
Ibrahim Ginawi
33 papers receiving 364 citations
Peers
Comparison fields: 5 of 96
- Nephrology 24
- Complementary and alternative medicine 27
- Toxicology 11
- Pharmacology 36
- Epidemiology 64
Countries citing papers authored by Ibrahim Ginawi
This map shows the geographic impact of Ibrahim Ginawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Ginawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Ginawi more than expected).
Fields of papers citing papers by Ibrahim Ginawi
This network shows the impact of papers produced by Ibrahim Ginawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Ginawi. The network helps show where Ibrahim Ginawi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim Ginawi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 53 | |
| 2 | 2011 | 38 | |
| 3 | 2014 | 37 | |
| 4 | 2010 | 34 | |
| 5 | 2017 | 33 | |
| 6 | Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats. | 2016 | 23 |
| 7 | 2016 | 18 | |
| 8 | 2013 | 15 | |
| 9 | 2024 | 13 | |
| 10 | Assessment of Risk Factors for Chronic Kidney Disease in Saudi Arabia | 2014 | 12 |
| 11 | 2014 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2015 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 2018 | 9 | |
| 16 | 2014 | 8 | |
| 17 | 2012 | 7 | |
| 18 | 2016 | 5 | |
| 19 | 2010 | 5 | |
| 20 | 2013 | 4 |
About Ibrahim Ginawi
Ibrahim Ginawi is a scholar working on Nephrology, Epidemiology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 33 papers that have together received 382 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Blood Pressure and Hypertension Studies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Diabetes and associated disorders (3 papers), Obesity, Physical Activity, Diet (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Public Health and Nutrition (2 papers) and Cardiovascular Disease and Adiposity (2 papers). The work is most often cited by research in Nephrology (24 citations), Complementary and alternative medicine (27 citations), Toxicology (11 citations), Pharmacology (36 citations) and Epidemiology (64 citations). Ibrahim Ginawi has collaborated with scholars based in Saudi Arabia, Sudan and United Kingdom. Frequent co-authors include Awdah Al-Hazimi, Hussain Gadelkarim Ahmed, Mohammed Kuddus, Ibraheem Ashankyty, Abdelbaset Mohamed Elasbali, Bright I. Nwaru, Paola Pisani, M Hakama, Mohamed H. Ahmed and Sufian K. Noor. Their work appears in journals such as Diagnostic Cytopathology, Journal of Obesity, Toxicology Reports, European Journal of Inflammation and Acta Diabetologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.